Melanoma, Skin cancer
Results
Phase 3
This trial looked at dabrafenib and trametinib for melanoma that had been removed. It was for people whose melanoma cells had a change in a called BRAF.
The trial was open for people to join between 2013 and 2014. The team published the results in 2020. There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 19 February 2013
Recruitment end: 22 September 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Paul Nathan
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
Novartis
NIHR Clinical Research Network: Cancer
Last reviewed: 14 March 2024
CRUK internal database number: 10184
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
